E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Zydus and MSN are the first companies to launch a generic version of Adempas (riociguat) in the US market.
imphoenix82
Speaking to Health Xplore on the sidelines of iPHEX 2026, Dr Shipra Pandey, Deputy Manager – International Business Development, Ratnatris Pharmaceuticals, discusses the company’s international expansion plans, expectations of foreign buyers, India’s dependence on Chinese APIs, and more.
dineshwori
Trident Lifeline’s Ashish Bafna talks about his experience at iPHEX 2026, the company’s expansion plans, the growing importance of quality in pharmaceutical manufacturing, and the need for greater alignment in policies and incentive schemes.
dineshwori
The 13th edition of iPHEX and the second Bharat Health Global Expo will be held from August 19 to 21, 2027, at Bharat Mandapam, New Delhi.
imphoenix82
The 12th edition of iPHEX is expected to bring together more than 800 exhibitors, over 600 overseas companies and around 30,000 business visitors.
imphoenix82
As India targets a USD 130 billion pharmaceutical market by 2030, several key factors are expected to drive its next phase of growth.
dineshworiHealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
